Evidence map›Paper›PMID 24557008›Full record

ArticleJournal of innate immunity2014

Relative contribution of c1q and apoptotic cell-surface calreticulin to macrophage phagocytosis.

Mélanie Verneret, Pascale Tacnet-Delorme, Rim Osman, Rida Awad, Alexei Grichine, Jean-Philippe Kleman, Philippe Frachet

Open access · bronzeAbstract read
In one paragraph

Article in Journal of innate immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Monocyte Production of C1q Potentiates CD8American journal of respiratory cell and molecular biology · 2024
    Article
  5. Review
  6. Article
  7. Causal relationship between complementFrontiers in genetics · 2024
    Article
  8. Review
  9. Article
  10. Review
  11. C1q and central nervous system disorders.Frontiers in immunology · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Calreticulin and cancer.Cell research · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Mélanie VerneretInstitut de Biologie Structurale (IBS), Immune Response to Pathogens and Altered Self (IRPAS) Group, Université Grenoble Alpes, Grenoble, France.
Pascale Tacnet-Delorme
Rim Osman
Rida Awad
Alexei Grichine
Jean-Philippe Kleman
Philippe Frachet
Commissariat à l'Énergie Atomique et aux Énergies Alternatives · FRCEA Grenoble · FRInserm · FRInstitut pour l'avancée des biosciences · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

C1q has been shown to recognize apoptotic cells, to enhance their uptake and to modulate cytokine release by phagocytes and thus promote immune tolerance. Surface-exposed calreticulin (CRT), known as a C1q receptor, is also considered to be an early eat-me signal that enhances the phagocytosis of apoptotic cells and is capable of eliciting an immunogenic response. However, the molecular mechanisms that trigger these functions are not clear. We hypothesized that CRT and C1q might act together in these processes. We first showed, by means of fluorescence resonance energy transfer (FRET), that CRT interacts with the C1q globular region at the surface of early apoptotic cells. Next, we pointed out that knockdown of CRT on early apoptotic HeLa cells impairs the enhancement effect of C1q on their uptake by THP-1 monocyte-derived macrophages. Furthermore, a deficiency of CRT induces contrasting effects on cytokine release by THP-1 macrophages, increasing interleukin (IL)-6 and monocyte chemotactic protein 1/CCL2 and decreasing IL-8. Remarkably, these effects were greatly reduced when apoptotic cells were opsonized by C1q, which counterbalanced the effect of the CRT deficiency. These results demonstrate that CRT-C1q interaction is involved in the C1q bridging function and they highlight the particular ability of C1q to control the phagocyte inflammatory status, i.e. by integrating the molecular changes that could occur at the surface of dying cells.

Indexed as

ApoptosisCalreticulinChemokine CCL2Complement C1qFluorescence Resonance Energy TransferGene Expression RegulationHeLa CellsHumansImmune ToleranceInterleukin-6Interleukin-8MacrophagesPhagocytosisProtein BindingCalreticulinChemokine CCL2Complement C1qInterleukin-6Interleukin-8

Identifiers

PMID24557008
PMCPMC6741593
OpenAlexW1981124925

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.